Lpath focuses on developing therapeutics that target bioactive lipids for treating a range of human diseases, including cancer and diseases that cause blindness. Its promising drugs have attracted attention — and lots of money…
Can a market research firm sell a doctor’s prescribing history to a pharmaceutical company without his or her permission? The U.S. Supreme Court has agreed to hear this First Amendment case, which could change drug marketing an…
If gasoline or jobs or milk were in short supply, we’d all know about it. But unknown to most Americans, the country is now in the grips of a life-threatening drug shortage. Medical professionals are quite aware of it, however,…
Mergers, acquisitions and major restructurings made Big Pharma a much smaller and leaner sector, with some 54,000 jobs lost. At least that’s better than 2009’s 61,000 layoffs.
Continue reading Which Sector Lost…
This little-known biopharmaceutical outfit has signed not just one but seven partnership pacts with Big Pharmas to help develop some of its products. Micromet’s No. 1 appeal: It’s developing novel antibody-based drugs to treat …